 |
Autologous ex-vivo-expanded peripheral polyclonal lymphocytes enriched in activated natural killer cells |
|---|---|
| Trade Name | |
| Orphan Indication | Multiple myeloma |
| EU Market Approval | EU |
| EU Designation Date | 2017-10-16 00:00:00 |
| Sponsor | CellProtect Nordic Pharmaceuticals AB |
Related Access Program
AbbVie – Multiple Myeloma
Janssen Research & Development, LLC – Multiple Myeloma
Dana-Farber Cancer Institute – Multiple Myeloma
Bristol-Myers Squibb – Multiple Myeloma
Peking University – Multiple Myeloma
Novartis Pharmaceuticals – Multiple Myeloma
Onyx Pharmaceuticals, Inc., an Amgen subsidiary – Multiple myeloma